{"id":622,"date":"2026-07-21T00:23:07","date_gmt":"2026-07-20T15:23:07","guid":{"rendered":"https:\/\/onepress.co.kr\/index.php\/briefing\/2026-07-21-ceftriaxone-resistant-gonorrhoea-europe-2026-ja\/"},"modified":"2026-07-21T13:47:09","modified_gmt":"2026-07-21T04:47:09","slug":"2026-07-21-ceftriaxone-resistant-gonorrhoea-europe-2026-ja","status":"publish","type":"briefing","link":"https:\/\/onepress.co.kr\/index.php\/briefing\/2026-07-21-ceftriaxone-resistant-gonorrhoea-europe-2026-ja\/","title":{"rendered":"\u6b27\u5dde\u5185\u3067\u5e83\u304c\u308b\u8010\u6027\u6dcb\u83cc\u3001\u30ea\u30b9\u30af\u304c\u9ad8\u3044\u306e\u306f\u8ab0\u304b"},"content":{"rendered":"<p><strong>2026-07-21 00:20 KST<\/strong><\/p>\n<p>ECDC\u306f\u3001\u30bb\u30d5\u30c8\u30ea\u30a2\u30ad\u30bd\u30f3\u8010\u6027\u6dcb\u83cc\u304cEU\u30fbEEA\u3068\u82f1\u56fd\u306e\u57df\u5185\u3067\u4f1d\u64ad\u3057\u3066\u3044\u308b\u3068\u8a55\u4fa1\u3057\u307e\u3057\u305f\u3002\u4e00\u822c\u7684\u306a\u30ea\u30b9\u30af\u306f\u4f4e\u3044\u3082\u306e\u306e\u3001\u8907\u6570\u30fb\u65b0\u898f\u30d1\u30fc\u30c8\u30ca\u30fc\u3068\u306e\u30b3\u30f3\u30c9\u30fc\u30e0\u3092\u4f7f\u308f\u306a\u3044\u6027\u884c\u70ba\u3084\u9ad8\u6d41\u884c\u5730\u57df\u3078\u306e\u65c5\u884c\u4e2d\u306e\u540c\u69d8\u306e\u63a5\u89e6\u3067\u306f\u9ad8\u307e\u308a\u307e\u3059\u3002<\/p>\n<h2>\u4f55\u304c\u5909\u308f\u308a\u3001\u30ea\u30b9\u30af\u306f\u3069\u306e\u7a0b\u5ea6\u304b<\/h2>\n<p>ECDC\u306f2026\u5e747\u670816\u65e5\u3001\u30bb\u30d5\u30c8\u30ea\u30a2\u30ad\u30bd\u30f3\u8010\u6027\u6dcb\u83cc\u304cEU\u30fbEEA\u3068\u82f1\u56fd\u306e\u57df\u5185\u3067\u4f1d\u64ad\u3057\u3066\u3044\u308b\u3068\u8a55\u4fa1\u3057\u307e\u3057\u305f\u3002\u4ee5\u524d\u306f\u65c5\u884c\u306b\u95a2\u9023\u3059\u308b\u6563\u767a\u4f8b\u304c\u4e2d\u5fc3\u3067\u3057\u305f\u304c\u30012025\uff5e2026\u5e74\u306b\u306f\u30d5\u30e9\u30f3\u30b9\u3001\u30c9\u30a4\u30c4\u3001\u30b9\u30a6\u30a7\u30fc\u30c7\u30f3\u3001\u82f1\u56fd\u3067\u5897\u52a0\u3068\u57df\u5185\u611f\u67d3\u30af\u30e9\u30b9\u30bf\u30fc\u304c\u78ba\u8a8d\u3055\u308c\u307e\u3057\u305f\u3002\u4e00\u822c\u306e\u6027\u7684\u6d3b\u52d5\u4eba\u53e3\u306e\u30ea\u30b9\u30af\u306f\u4f4e\u3044\u3001\u8907\u6570\u307e\u305f\u306f\u983b\u7e41\u306b\u5909\u308f\u308b\u30d1\u30fc\u30c8\u30ca\u30fc\u3084\u65b0\u898f\u30fb\u4e00\u6642\u7684\u30d1\u30fc\u30c8\u30ca\u30fc\u3068\u306e\u30b3\u30f3\u30c9\u30fc\u30e0\u3092\u4f7f\u308f\u306a\u3044\u6027\u884c\u70ba\u3067\u306f\u4f4e\uff5e\u4e2d\u3001\u9ad8\u6d41\u884c\u5730\u57df\u3078\u306e\u65c5\u884c\u4e2d\u306b\u540c\u69d8\u306e\u63a5\u89e6\u304c\u3042\u3063\u305f\u5834\u5408\u306f\u4e2d\u3068\u8a55\u4fa1\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<h2>\u8010\u6027\u306f\u76f4\u3061\u306b\u6cbb\u7642\u4e0d\u80fd\u3092\u610f\u5473\u3057\u306a\u3044<\/h2>\n<p>\u30bb\u30d5\u30c8\u30ea\u30a2\u30ad\u30bd\u30f3\u306f\u6b27\u5dde\u3067\u63a8\u5968\u3055\u308c\u308b\u7b2c\u4e00\u9078\u629e\u6cbb\u7642\u306e\u4e2d\u5fc3\u3067\u3042\u308a\u3001\u8010\u6027\u304c\u5e83\u304c\u308c\u3070\u85ac\u306e\u9078\u629e\u80a2\u304c\u6e1b\u308b\u6050\u308c\u304c\u3042\u308a\u307e\u3059\u3002\u305f\u3060\u3057\u3001\u3053\u308c\u307e\u3067\u306b\u5831\u544a\u3055\u308c\u305f\u611f\u67d3\u306f\u3059\u3079\u3066\u6cbb\u7642\u306b\u6210\u529f\u3057\u3066\u3044\u307e\u3059\u3002\u300c\u8010\u6027\u300d\u3092\u76f4\u3061\u306b\u300c\u6cbb\u7642\u4e0d\u80fd\u300d\u3068\u8a00\u3044\u63db\u3048\u308b\u3079\u304d\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002\u6301\u7d9a\u7684\u306a\u4f1d\u64ad\u306b\u3088\u3063\u3066\u6a19\u6e96\u6cbb\u7642\u306e\u6709\u52b9\u6027\u304c\u4e0b\u304c\u308a\u3001\u60a3\u8005\u3054\u3068\u306b\u6709\u52b9\u306a\u85ac\u3092\u9078\u3076\u3053\u3068\u304c\u96e3\u3057\u304f\u306a\u308b\u53ef\u80fd\u6027\u304c\u8b66\u544a\u306e\u6838\u5fc3\u3067\u3059\u3002<\/p>\n<figure class=\"wp-block-image size-full\"><img decoding=\"async\" src=\"https:\/\/onepress.co.kr\/wp-content\/uploads\/2026\/07\/ceftriaxone-resistant-gonorrhoea-europe-2026-ja.png\" alt=\"\u6297\u83cc\u85ac\u8010\u6027\u6dcb\u83cc\u3092\u89e3\u6790\u3059\u308b\u81e8\u5e8a\u5fae\u751f\u7269\u691c\u67fb\u5ba4\u306e\u5236\u4f5c\u753b\u50cf\" loading=\"eager\" \/><figcaption class=\"op-briefing-image-caption\">\u751f\u6210\u753b\u50cf\uff1aONEPRESS\u304c\u57f9\u990a\u691c\u67fb\u3068\u30b2\u30ce\u30e0\u8010\u6027\u89e3\u6790\u3092\u6982\u5ff5\u7684\u306b\u8868\u73fe\u3057\u307e\u3057\u305f\u3002\u60a3\u8005\u60c5\u5831\u3084\u5b9f\u969b\u306e\u9855\u5fae\u93e1\u5199\u771f\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002<\/figcaption><\/figure>\n<h2>\u76e3\u8996\u30c7\u30fc\u30bf\u304c\u793a\u3059\u8b66\u544a<\/h2>\n<p>2024\u5e74\u306eEuro-GASP\u306b\u306f24\u304b\u56fd\u304c\u53c2\u52a0\u3057\u30014516\u682a\u304c\u63d0\u51fa\u3055\u308c\u30013371\u682a\u304c\u89e3\u6790\u5bfe\u8c61\u3068\u306a\u308a\u307e\u3057\u305f\u3002\u30bb\u30d5\u30c8\u30ea\u30a2\u30ad\u30bd\u30f3\u8010\u6027\u306f2\u682a\u3067\u3001\u3044\u305a\u308c\u3082\u5e83\u7bc4\u56f2\u85ac\u5264\u8010\u6027\u3067\u3057\u305f\u3002\u30a2\u30b8\u30b9\u30ed\u30de\u30a4\u30b7\u30f3\u8010\u6027\u306e\u6307\u6a19\u306f19.1\uff05\u3067\u300124\u304b\u56fd\u4e2d23\u304b\u56fd\u3067\u78ba\u8a8d\u3055\u308c\u307e\u3057\u305f\u3002EU\u30fbEEA\u3067\u306f2024\u5e74\u306b10\u4e076000\u4ef6\u3092\u8d85\u3048\u308b\u6dcb\u83cc\u611f\u67d3\u75c7\u304c\u5831\u544a\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u8010\u6027\u682a\u306e\u6570\u304c\u5c0f\u3055\u304f\u3066\u3082\u6cbb\u7642\u306e\u9078\u629e\u80a2\u304c\u9650\u3089\u308c\u308b\u305f\u3081\u76e3\u8996\u304c\u5fc5\u8981\u3067\u3059\u3002<\/p>\n<h2>\u611f\u67d3\u6a5f\u4f1a\u304c\u5fc3\u914d\u306a\u3068\u304d\u306b\u3059\u308b\u3053\u3068<\/h2>\n<p>\u611f\u67d3\u6a5f\u4f1a\u3084\u5206\u6ccc\u7269\u3001\u6392\u5c3f\u75db\u306a\u3069\u306e\u75c7\u72b6\u304c\u5fc3\u914d\u306a\u5834\u5408\u306f\u3001\u81ea\u5df1\u5224\u65ad\u3067\u6297\u83cc\u85ac\u3092\u98f2\u307e\u305a\u6027\u611f\u67d3\u75c7\u691c\u67fb\u3092\u53d7\u3051\u3066\u304f\u3060\u3055\u3044\u3002\u7121\u75c7\u72b6\u306e\u3053\u3068\u3082\u3042\u308a\u3001\u5fc5\u8981\u306a\u691c\u4f53\u306f\u63a5\u89e6\u90e8\u4f4d\u3067\u7570\u306a\u308b\u305f\u3081\u3001\u53e3\u8154\u30fb\u6027\u5668\u30fb\u76f4\u8178\u306e\u63a5\u89e6\u3092\u533b\u7642\u5f93\u4e8b\u8005\u306b\u4f1d\u3048\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002\u6cbb\u7642\u306f\u56fd\u5185\u6307\u91dd\u306b\u5f93\u3044\u3001\u8010\u6027\u611f\u67d3\u3084\u6cbb\u7642\u5931\u6557\u304c\u7591\u308f\u308c\u308b\u5834\u5408\u306f\u57f9\u990a\u3001\u85ac\u5264\u611f\u53d7\u6027\u691c\u67fb\u3001\u6cbb\u7652\u78ba\u8a8d\u304c\u7279\u306b\u91cd\u8981\u3067\u3059\u3002\u30d1\u30fc\u30c8\u30ca\u30fc\u3078\u306e\u9023\u7d61\u3068\u691c\u67fb\u3082\u518d\u611f\u67d3\u3068\u8ffd\u52a0\u4f1d\u64ad\u3092\u6e1b\u3089\u3057\u307e\u3059\u3002<\/p>\n<h2>ECDC\u8cc7\u6599\u3067\u76f4\u63a5\u78ba\u8a8d\u3059\u308b\u3053\u3068<\/h2>\n<p>ECDC\u306e\u30ea\u30b9\u30af\u8a55\u4fa1\u3067\u306f\u57df\u5185\u4f1d\u64ad\u306e\u6839\u62e0\u3001\u63a5\u89e6\u6761\u4ef6\u5225\u306e\u30ea\u30b9\u30af\u3001\u691c\u67fb\u30fb\u6cbb\u7642\u30fb\u6cbb\u7652\u78ba\u8a8d\u306e\u52e7\u544a\u3092\u78ba\u8a8d\u3067\u304d\u307e\u3059\u3002Euro-GASP\u5831\u544a\u306f\u83cc\u682a\u6570\u3068\u8010\u6027\u30c7\u30fc\u30bf\u3092\u793a\u3057\u3001\u76e3\u8996\u30da\u30fc\u30b8\u306f\u5e74\u6b21\u8cc7\u6599\u306b\u3064\u306a\u304c\u308a\u307e\u3059\u3002\u3053\u306e\u8a55\u4fa1\u306f\u56fd\u3084\u96c6\u56e3\u3092\u975e\u96e3\u3059\u308b\u6839\u62e0\u3067\u306f\u306a\u304f\u3001\u6b27\u5dde\u5168\u4f53\u304c\u6cbb\u7642\u4e0d\u80fd\u306a\u6d41\u884c\u306b\u5165\u3063\u305f\u3068\u3044\u3046\u610f\u5473\u3067\u3082\u3042\u308a\u307e\u305b\u3093\u3002\u500b\u4eba\u306e\u691c\u67fb\u3068\u6cbb\u7642\u306f\u5730\u57df\u306e\u4fdd\u5065\u5f53\u5c40\u3068\u533b\u7642\u6a5f\u95a2\u306e\u6307\u91dd\u306b\u5f93\u3063\u3066\u304f\u3060\u3055\u3044\u3002<\/p>\n<p><a href=\"https:\/\/www.ecdc.europa.eu\/en\/publications-data\/upsurge-ceftriaxone-resistant-neisseria-gonorrhoeae-evidence-domestic\" target=\"_blank\" rel=\"noopener noreferrer\">ECDC\u8010\u6027\u6dcb\u83cc\u30ea\u30b9\u30af\u8a55\u4fa1\u3068\u63a5\u89e6\u5225\u30ea\u30b9\u30af<\/a><\/p>\n<p><a href=\"https:\/\/www.ecdc.europa.eu\/en\/publications-data\/gonococcal-antimicrobial-susceptibility-surveillance-european-union-european\" target=\"_blank\" rel=\"noopener noreferrer\">Euro-GASP 2024\u85ac\u5264\u611f\u53d7\u6027\u30c7\u30fc\u30bf<\/a><\/p>\n<p><a href=\"https:\/\/www.ecdc.europa.eu\/en\/gonorrhoea\/surveillance-and-disease-data\" target=\"_blank\" rel=\"noopener noreferrer\">ECDC\u6dcb\u83cc\u76e3\u8996\u3068\u5e74\u6b21\u8cc7\u6599<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>ECDC\u306f\u3001\u30bb\u30d5\u30c8\u30ea\u30a2\u30ad\u30bd\u30f3\u8010\u6027\u6dcb\u83cc\u304cEU\u30fbEEA\u3068\u82f1\u56fd\u306e\u57df\u5185\u3067\u4f1d\u64ad\u3057\u3066\u3044\u308b\u3068\u8a55\u4fa1\u3057\u307e\u3057\u305f\u3002\u4e00\u822c\u7684\u306a\u30ea\u30b9\u30af\u306f\u4f4e\u3044\u3082\u306e\u306e\u3001\u8907\u6570\u30fb\u65b0\u898f\u30d1\u30fc\u30c8\u30ca\u30fc\u3068\u306e\u30b3\u30f3\u30c9\u30fc\u30e0\u3092\u4f7f\u308f\u306a\u3044\u6027\u884c\u70ba\u3084\u9ad8\u6d41\u884c\u5730\u57df\u3078\u306e\u65c5\u884c\u4e2d\u306e\u540c\u69d8\u306e\u63a5\u89e6\u3067\u306f\u9ad8\u307e\u308a\u307e\u3059\u3002<\/p>\n","protected":false},"featured_media":0,"template":"","meta":[],"class_list":["post-622","briefing","type-briefing","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/onepress.co.kr\/index.php\/wp-json\/wp\/v2\/briefing\/622","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/onepress.co.kr\/index.php\/wp-json\/wp\/v2\/briefing"}],"about":[{"href":"https:\/\/onepress.co.kr\/index.php\/wp-json\/wp\/v2\/types\/briefing"}],"wp:attachment":[{"href":"https:\/\/onepress.co.kr\/index.php\/wp-json\/wp\/v2\/media?parent=622"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}